01 May 2026
// PRESS RELEASE
26 Jan 2026
// PRESS RELEASE
03 Jul 2025
// PRESS RELEASE
Latest Content by PharmaCompass
KEY PRODUCTS
Reset all filters
01 7Noramco, Inc.
Reset all filters
01 5No Action Indicated
02 2Voluntary Action Indicated
Reset all filters
01 12022-11-18
02 12019-02-21
03 12017-11-17
04 12016-01-21
05 12014-11-13
06 12012-04-27
07 12010-08-02
Reset all filters
01 7Wilmington
Reset all filters
01 7U.S.A
District Decision : No Action Indicated
Inspection End Date : 2022-11-18
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2022-11-18
District Decision : No Action Indicated
Inspection End Date : 2019-02-21
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2019-02-21
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-11-17
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-11-17
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
District Decision : No Action Indicated
Inspection End Date : 2014-11-13
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2014-11-13
District Decision : No Action Indicated
Inspection End Date : 2012-04-27
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2012-04-27
District Decision : Voluntary Action Indicated
Inspection End Date : 2010-08-02
City : Wilmington
State : Delaware
Country/Area : U.S.A
Zip : 19801
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2010-08-02
Noramco is a supplier offers 25 products (APIs, Excipients or Intermediates).
Find Buprenorphine Hydrochloride bulk with DMF, CEP offered by Noramco
Find Hydromorphone Hydrochloride bulk with DMF, CEP offered by Noramco
Find Methylphenidate Hydrochloride bulk with DMF, CEP offered by Noramco
Find Naloxone Hydrochloride bulk with DMF, CEP offered by Noramco
Find Naltrexone Hydrochloride bulk with DMF, CEP offered by Noramco
Find Oxycodone Hydrochloride bulk with DMF, CEP offered by Noramco
Find Buprenorphine bulk with DMF offered by Noramco
Find Buprenorphine Hydrochloride bulk with DMF offered by Noramco
Find Codeine Phosphate bulk with DMF offered by Noramco
Find Hydrocodone Bitartrate bulk with DMF offered by Noramco
Find Levorphanol Tartrate bulk with DMF offered by Noramco
Find Lisdexamfetamine Dimesylate bulk with DMF offered by Noramco
Find Methylphenidate Hydrochloride bulk with DMF offered by Noramco
Find Morphine Sulfate bulk with DMF offered by Noramco
Find Naltrexone bulk with DMF offered by Noramco
Find Oxycodone Hydrochloride bulk with DMF offered by Noramco
Find Oxymorphone Hydrochloride bulk with DMF offered by Noramco
Find Tapentadol bulk with DMF offered by Noramco
Find Cannabidiol bulk offered by Noramco
Find Dexmethylphenidate bulk offered by Noramco
Find Nabilone bulk offered by Noramco
Find Naltrexone Methobromide bulk offered by Noramco
Find Oxymorphone bulk offered by Noramco
Find Sodium Oxybate bulk offered by Noramco
Find Tetrahydrocannabinol bulk offered by Noramco